• Blog
  • Bone Morphogenetic Proteins Market Report

    Bone Morphogenetic Proteins Market Report

    Bone Morphogenetic Proteins Market Report
    Report code - SR1718 Delivery - 2 Weeks
    Bone Morphogenetic Proteins Market Size, Share, Trend, Forecast, & Industry Analy See more...

    Market Insights

    What are bone morphogenic proteins?

    Bone morphogenetic proteins (BMPs) are signaling molecules and most of them are a part of the Transforming Growth Factor-β (TGFβ) family of proteins. These proteins have a key role in bone and cartilage formation and embryogenesis. Bone morphogenetics further plays a major role in the development of the central nervous system.

    The Bone Morphogenetic Proteins market is projected to grow from USD 542.3 million in 2020 to USD 633.1 million by 2026 at a CAGR of over 2.6% during the forecast period.

    Bone Morphogenetic Proteins Market - Research Scope

    Base Year of Study

    2020

    Trend Period

    2015-2019

    Forecast Period

    2021-2026

    Market Size in 2020

    USD 542.3 million

    Market Size in 2026

    USD 633.1 million

    Market Growth (2021-2026)

    2.6% CAGR

     

    Figure: Bone Morphogenetic Proteins Market Size, 2020-2026 (USD Million)

    Bone-Morphogenic-Proteins-Market-Forecast

    Wish to get a free sample. Register Here

    Market Drivers

    The rising number of people suffering from spinal injuries along with a surge in surgical rates are expected to boost the industry growth in the coming years. Also, ongoing research undertaken by different manufacturing companies for discovering the therapeutic potential of BMP in various orthopedic disorders, including soft tissue repair and osteoarthritis, is likely to bolster the product demand. In addition, the growing number of spinal injuries, sedentary lifestyle, sport-related injuries, and bad posture, further drive the market growth during the forecast timeline.

    COVID-19 Impact on Bone Morphogenetic Proteins Market

    The COVID-19 pandemic has moderately affected the bone morphogenetic proteins industry. The rapid spread of COVID-19 has led to several thousands of hospital admissions. The focus of healthcare professionals has been shifted toward the treatment of COVID-19-infected patients, which affected the treatment of non-emergency medical conditions, amid the pandemic.

    Segments' Analysis

    Application Trends

    Based on application, the bone morphogenetic proteins market has been classified into spinal fusion, trauma, reconstructive surgery, and oral-maxillofacial. Under these, spinal fusion held the largest market share in 2020 and is likely to grow at a considered CAGR during the forecast period. Degenerative disc disorder of the spine is mainly due to accidental falls, sports injuries, or osteoporosis in the aging population. Also, the presence of favorable reimbursement policies for spine infusion procedures further bolsters the segment growth.

    Regional Trends

    By region, the North American market held a significant market share in 2020 and is projected to grow at a healthy CAGR in the coming years. Rising healthcare expenditure, growing awareness regarding minimally invasive BMP procedures, strong adoption of advanced technology by orthopedic surgeons, well-established healthcare infrastructure, and favorable reimbursement structure, augment the regional market growth during the forecast timeline.

    Critical Questions Answered in the Report

    This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global bone morphogenetic proteins market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026. Following are the critical questions answered in the report-

    • What are the key trends in the bone morphogenetic proteins market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the bone morphogenetic proteins market? 
    • What are the key strategies adopted by the major vendors to lead in the bone morphogenetic proteins market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Key Players

    Key players operating in the bone morphogenetic proteins market are-

    • Johnson & Johnson (US)
    • Ember therapeutics Inc. (US)
    • Integra Lifesciences Holdings Corporation (US)
    • Medtronic PLC (Ireland)
    • Bio-Techne (R&D Systems, Inc.) (US)
    • Merck KGaA (Germany)
    • Pfizer, Inc. (US)
    • Stryker Corporation (US)
    • Thermo Fischer Scientific (US)
    • Zimmer Biomet Holdings, Inc. (US)

    Target Audience

    Here is the list of the group of customers that the Bone Morphogenetic Proteins Market hopes to have the greatest opportunity to convert-

    • Bone Morphogenetic Proteins companies
    • Bone Morphogenetic Proteins distributors
    • Medical companies
    • Government organizations

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The bone morphogenetic proteins market is expected to witness an impressive growth of 2.6% CAGR in the coming years.

    Johnson & Johnson (US), Ember therapeutics Inc. (US), Integra Lifesciences Holdings Corporation (US), Medtronic PLC (Ireland), Bio-Techne (R&D Systems, Inc.) (US), Merck KGaA (Germany), Pfizer, Inc. (US), Stryker Corporation (US), Thermo Fischer Scientific (US), and Zimmer Biomet Holdings, Inc. (US) are among the key players in the bone morphogenetic proteins market.

    The bone morphogenetic proteins market size is expected to reach USD 633.1 million in the foreseeable future.

    Spinal fusion held the largest share in the bone morphogenetic proteins market in 2020.

    North America is expected to grow at a healthy CAGR in the bone morphogenetic proteins market in the next five years.

    Bone Morphogenetic Proteins companies, Bone Morphogenetic Proteins distributors, Medical companies, Government organizations are the target audience in the bone morphogenetic proteins market.